BEYOND AIR INC (XAIR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$2.33+0.43%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · XAIR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -89.3% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 29 industry peers
XAIR — private placement
Dated 2026-07-31
Entry Into a Material Definitive Agreement. On July 29, 2026, Beyond Air, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors and certain directors and executive officers of the Company (collectively, the “Investors”). Pursuant to the Purchase Agreement, the Company agreed to issue and sell to the Investors, severally and not jointly, in a private placement (the “Private Placement”) (i) an aggregate of 167,011 share…
Why it matters: The $2.3 million figure is preliminary. The final report will show whether the record quarter held up.
Watch forThe November 9 report confirms Q3 revenue of about $2.3 million or more.
Also watch forThe November 9 report shows Q3 revenue below $2.3 million.
Why it matters: The financing includes $10.2 million upfront and more funds if warrants are used. The company reported losses and debt, so cash raised matters.
Watch forThe company says warrant exercises bring in more funding.
Also watch forThe company reports no further warrant proceeds and cash falls from the $15.2 million reported at June 30, 2026.
Why it matters: The company reaffirmed its $8 million CY2026 revenue guide. Q3 growth gives a new test of that target.
Watch forReported CY2026 revenue is at least $8 million.
Also watch forReported CY2026 revenue is below $8 million.
Why it matters: The new group purchasing deal reaches nearly 2,000 more hospitals and health systems. More hospital use can support sales growth.
Supportive ifA later report links U.S. LungFit PH sales growth to new hospitals reached through the GPO deal.
Worry ifA later report shows U.S. LungFit PH sales are flat or lower year over year despite the added hospital access.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$308 on $10,000 · ±3.1% | How much price usually moves either way. |
| Bad day | $1,076 loss on $10,000 · 10.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,523 loss on $10,000 · 95.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.